KRISTEN KELLER: Open Payments
NPI 1437686375 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 61 payments from 14 companies in 2025. Trend: 2023 $981 · 2024 $1,190 · 2025 $1,266
Food & beverage: $1,211Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $334 |
| Arcutis Biotherapeutics, Inc. | 21 | $232 |
| ABBVIE INC. | 11 | $203 |
| Lilly USA, LLC | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| GENZYME CORPORATION | 2 | $75 |
| Organon LLC | 2 | $52 |
| Amgen Inc. | 2 | $48 |
| PFIZER INC. | 2 | $30 |
| UCB, Inc. | 1 | $30 |
Products named: TREMFYA, Zoryve, DUPIXENT, SKYRIZI, COSENTYX, RINVOQ, EBGLYSS, VTAMA.
Industry payments across VA — which companies pay providers there.
